157 related articles for article (PubMed ID: 25626323)
21. Multiple myeloma and other malignancies: a pilot study from the Houston VA.
Munker R; Shi R; Lin D; Guo S; Hayes TG
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):102-6. PubMed ID: 24373789
[TBL] [Abstract][Full Text] [Related]
22. The risk of secondary primary malignancies after therapy for multiple myeloma.
Areethamsirikul N; Reece DE
Leuk Lymphoma; 2015; 56(11):3012-21. PubMed ID: 25947036
[TBL] [Abstract][Full Text] [Related]
23. Review of therapy for relapsed/refractory multiple myeloma: focus on lenalidomide.
Mariz JM; Esteves GV
Curr Opin Oncol; 2012 Jan; 24 Suppl 2():S3-11. PubMed ID: 22245806
[TBL] [Abstract][Full Text] [Related]
24. Clinical management of myeloma--state of the art.
Harousseau JL
Cancer Treat Rev; 2010 May; 36 Suppl 2():S1-2. PubMed ID: 20472182
[TBL] [Abstract][Full Text] [Related]
25. New treatments for multiple myeloma.
Richardson PG; Schlossman R; Hideshima T; Anderson KC
Oncology (Williston Park); 2005 Dec; 19(14):1781-92; discussion 1792, 1795-7. PubMed ID: 16506632
[TBL] [Abstract][Full Text] [Related]
26. Lenalidomide: new drug. Myeloma: many questions remain unanswered.
Prescrire Int; 2008 Dec; 17(98):230-2. PubMed ID: 19422142
[TBL] [Abstract][Full Text] [Related]
27. Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?
Palumbo A; Mateos MV; Bringhen S; San Miguel JF
Blood Rev; 2011 Jul; 25(4):181-91. PubMed ID: 21497966
[TBL] [Abstract][Full Text] [Related]
28. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
Nucci M; Anaissie E
Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
[TBL] [Abstract][Full Text] [Related]
29. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma.
Bladé J; Cibeira MT; Rosiñol L
Acta Oncol; 2005; 44(5):440-8. PubMed ID: 16118077
[TBL] [Abstract][Full Text] [Related]
30. [Second primary malignancies among patients with myeloma-related-diseases in the KMF database].
Kosugi S; Shibayama H; Nakatani E; Kida T; Ohta K; Kaneko H; Yagi H; Tanaka H; Fuchida S; Nakaya A; Kobayashi M; Kuroda J; Kamitsuji Y; Uoshima N; Adachi Y; Tsudo M; Shimazaki C; Nomura S; Hino M; Matsumura I; Taniwaki M; Kanakura Y; Takaori-Kondo A
Rinsho Ketsueki; 2016 Jul; 57(7):839-47. PubMed ID: 27498726
[TBL] [Abstract][Full Text] [Related]
31. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
32. Management of newly diagnosed myeloma.
Rajkumar SV; Palumbo A
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1141-56, ix-x. PubMed ID: 17996592
[TBL] [Abstract][Full Text] [Related]
33. Lenalidomide and its role in the management of multiple myeloma.
Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
[TBL] [Abstract][Full Text] [Related]
34. Bortezomib in the front-line treatment of multiple myeloma.
Richardson PG; Mitsiades C; Schlossman R; Ghobrial I; Hideshima T; Munshi N; Anderson KC
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1053-72. PubMed ID: 18588451
[TBL] [Abstract][Full Text] [Related]
35. Treatment of multiple myeloma: 2009 update.
Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
[TBL] [Abstract][Full Text] [Related]
36. Emerging drugs in multiple myeloma.
Ghobrial IM; Leleu X; Hatjiharissi E; Hideshima T; Mitsiades C; Schlossman R; Anderson KC; Richardson P
Expert Opin Emerg Drugs; 2007 Mar; 12(1):155-63. PubMed ID: 17355220
[TBL] [Abstract][Full Text] [Related]
37. Continuous lenalidomide treatment for newly diagnosed multiple myeloma.
Palumbo A; Hajek R; Delforge M; Kropff M; Petrucci MT; Catalano J; Gisslinger H; Wiktor-Jędrzejczak W; Zodelava M; Weisel K; Cascavilla N; Iosava G; Cavo M; Kloczko J; Bladé J; Beksac M; Spicka I; Plesner T; Radke J; Langer C; Ben Yehuda D; Corso A; Herbein L; Yu Z; Mei J; Jacques C; Dimopoulos MA;
N Engl J Med; 2012 May; 366(19):1759-69. PubMed ID: 22571200
[TBL] [Abstract][Full Text] [Related]
38. Management of older patients with multiple myeloma.
Gay F; Palumbo A
Blood Rev; 2011 Mar; 25(2):65-73. PubMed ID: 21295387
[TBL] [Abstract][Full Text] [Related]
39. Current therapeutic strategy for multiple myeloma.
Suzuki K
Jpn J Clin Oncol; 2013 Feb; 43(2):116-24. PubMed ID: 23293370
[TBL] [Abstract][Full Text] [Related]
40. Role of thalidomide in the treatment of patients with multiple myeloma.
Morgan GJ; Davies FE
Crit Rev Oncol Hematol; 2013 Oct; 88 Suppl 1():S14-22. PubMed ID: 23827438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
